Recent Approaches of Drugs and Vaccines Used in COVID 19: A Review
S. Sivakumar, K. Kathiresan, P. Pandian
Journal of Pharmaceutical Research International · pp. 1–10 · Published 10 Mar 2022
10.9734/jpri/2022/v34i22A35848Abstract
A novel SARS-CoV-2 coronavirus developed in December 2019, triggering a life-threatening pneumonia outbreak in China, and has since expanded worldwide, producing a pandemic. Because of the urgent need to control the disease and the dearth of specific and effective treatment options, FDA-approved medicines that have proven efficacy against comparable viruses are being used. In vitro, chloroquine, remdesivir, lopinavir/ritonavir or ribavirin are effective at inhibiting SARS-CoV-2. The preliminary findings of a variety of clinical trials utilising various chloroquine or hydroxychloroquine delivery procedures all indicate a positive outcome. They may not be effective in cases of consistently high viremia, and data on ivermectin (another antiparasitic medication) is currently unavailable. Intriguingly, azithromycin, a macrolide antibiotic, in conjunction with hydroxychloroquine may provide therapeutic benefits. Favipiravir, tocilizumab, and azithromycin types are among the other treatment options being investigated.
Cited by 0
No indexed citations yet.
Related research
- Knowledge, Acceptance and Perception on COVID-19 Vaccine among Sudanese People in Khartoum State, 2020-2021 — shares topic coverage
- Aerosols in Dental Practice- A Neglected Infectious Vector — shares topic coverage
- Descriptive Analysis of Ebola virus Proteins: Towards Development of Effective Therapeutics and Vaccines — shares topic coverage
- Reports on COVID-19 Vaccines and Vaccination in Nigeria — shares topic coverage
- The New Pandemic Covid-19: Treatment Options and Developments — shares topic coverage
Article metrics
Real usage data collected on this platform.
1
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.